{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T06:00:15Z","timestamp":1773036015535,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T00:00:00Z","timestamp":1567814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T00:00:00Z","timestamp":1567814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Erasmus University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s10096-019-03672-2","type":"journal-article","created":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T11:02:51Z","timestamp":1567854171000},"page":"2283-2290","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Use of other antimicrobial drugs is associated with trimethoprim resistance in patients with urinary tract infections caused by E. coli"],"prefix":"10.1007","volume":"38","author":[{"given":"M.","family":"Mulder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Verbon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Lous","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Goessens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. H.","family":"Stricker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,9,7]]},"reference":[{"key":"3672_CR1","doi-asserted-by":"publisher","first-page":"c2096","DOI":"10.1136\/bmj.c2096","volume":"340","author":"C Costelloe","year":"2010","unstructured":"Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD (2010) Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ 340:c2096","journal-title":"BMJ"},{"issue":"3","key":"3672_CR2","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1128\/AAC.01188-08","volume":"53","author":"RP Olson","year":"2009","unstructured":"Olson RP, Harrell LJ, Kaye KS (2009) Antibiotic resistance in urinary isolates of Escherichia coli from college women with urinary tract infections. Antimicrob Agents Chemother 53(3):1285\u20131286","journal-title":"Antimicrob Agents Chemother"},{"key":"3672_CR3","unstructured":"2010\u20132011 NM monitoring of antimicrobial resistance and antibiotic usage in animals in the Netherlands in 2010\/2011; Nethmap: consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in the Netherlands. NETHMAP. \nhttps:\/\/www.wur.nl\/nl\/Onderzoek-Resultaten\/Onderzoeksinstituten\/Bioveterinary-Research\/Uitgelicht-1\/Antibioticaresistentie-2\/MARANrapporten.htm\n\n. Accessed 2 Aug 2019"},{"key":"3672_CR4","unstructured":"Public Health England (2017) English surveillance programme for antimicrobial utilisation and resistance (ESPAUR). Public Health England. \nhttps:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/759975\/ESPAUR_2018_report.pdf\n\n. Accessed 2 Aug 2019"},{"issue":"7","key":"3672_CR5","first-page":"341","volume":"48","author":"KAMV van Haaren","year":"2005","unstructured":"van Haaren KAMV, S H, van Vliet S, Timmermans AE, Yadava R, Geerlings SE, ter Riet G, van Pinxteren B (2005) NHG-Standaard Urineweginfecties Huisarts en Wetenschap 48(7):341\u2013352","journal-title":"NHG-Standaard Urineweginfecties Huisarts en Wetenschap"},{"issue":"6","key":"3672_CR6","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1093\/jac\/47.6.781","volume":"47","author":"DTS Steinke","year":"2001","unstructured":"Steinke DTS, Phillips RA, MacDonald G, Davey TM, G P (2001) Prior trimethoprim use and trimethoprim-resistant urinary tract infection: a nested case-control study with multivariate analysis for other risk factors. J Antimicrob Chemother 47(6):781\u2013787","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"3672_CR7","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.coph.2011.07.007","volume":"11","author":"R Canton","year":"2011","unstructured":"Canton R, Ruiz-Garbajosa P (2011) Co-resistance: an opportunity for the bacteria and resistance genes. Curr Opin Pharmacol 11(5):477\u2013485","journal-title":"Curr Opin Pharmacol"},{"issue":"6","key":"3672_CR8","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1093\/jac\/dky031","volume":"73","author":"Koen B Pouwels","year":"2018","unstructured":"Pouwels KB, Freeman R, Muller-Pebody B, Rooney G, Henderson KL, Robotham JV, Smieszek T (2018) Association between use of different antibiotics and trimethoprim resistance: going beyond the obvious crude association. J Antimicrob Chemother 73(6):1700\u20131707","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"13","key":"3672_CR9","first-page":"613","volume":"42","author":"AE Timmermans","year":"1999","unstructured":"Timmermans AE, Baselier PJAM, Winkens RAG, Arets H, Wiersma T (1999) NHG-Standaard Urineweginfecties. Huisarts en Wetenschap 42(13):613\u2013622","journal-title":"Huisarts en Wetenschap"},{"issue":"6","key":"3672_CR10","first-page":"270","volume":"56","author":"B van Pinxteren","year":"2013","unstructured":"van Pinxteren B, Knottnerus B, Geerlins S, Visser H, Klinkhamer S, van der Weele G, Verduijn M, Opstelten W, Burgers J, van Asselt K (2013) NHG Standaard Urineweginfecties. Huisarts Wet 56(6):270\u2013280","journal-title":"Huisarts Wet"},{"key":"3672_CR11","volume-title":"NethMap 2018: consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in the Netherlands","author":"SCMJ de Greef","year":"2018","unstructured":"de Greef SCMJ (2018) NethMap 2018: consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in the Netherlands. RIVM, Bilthoven"},{"issue":"9","key":"3672_CR12","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s10654-017-0321-4","volume":"32","author":"MA Ikram","year":"2017","unstructured":"Ikram MA, Brusselle GGO, Murad SD, van Duijn CM, Franco OH, Goedegebure A, Klaver CCW, Nijsten TEC, Peeters RP, Stricker BH, Tiemeier H, Uitterlinden AG, Vernooij MW, Hofman A (2017) The Rotterdam Study: 2018 update on objectives, design and main results. Eur J Epidemiol 32(9):807\u2013850","journal-title":"Eur J Epidemiol"},{"issue":"9","key":"3672_CR13","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, Ckd EPI (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150(9):604\u2013612","journal-title":"Ann Intern Med"},{"key":"3672_CR14","doi-asserted-by":"publisher","first-page":"b2393","DOI":"10.1136\/bmj.b2393","volume":"338","author":"JA Sterne","year":"2009","unstructured":"Sterne JA, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, Wood AM, Carpenter JR (2009) Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ 338:b2393","journal-title":"BMJ"},{"issue":"3","key":"3672_CR15","first-page":"69","volume":"24","author":"MM Mukaka","year":"2012","unstructured":"Mukaka MM (2012) Statistics corner: a guide to appropriate use of correlation coefficient in medical research. Malawi Med J 24(3):69\u201371","journal-title":"Malawi Med J"},{"issue":"3","key":"3672_CR16","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1093\/jac\/dkn222","volume":"62","author":"L Sandegren","year":"2008","unstructured":"Sandegren L, Lindqvist A, Kahlmeter G, Andersson DI (2008) Nitrofurantoin resistance mechanism and fitness cost in Escherichia coli. J Antimicrob Chemother 62(3):495\u2013503","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"3672_CR17","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1128\/AAC.02156-15","volume":"60","author":"PL Ho","year":"2016","unstructured":"Ho PL, Ng KY, Lo WU, Law PY, Lai EL, Wang Y, Chow KH (2016) Plasmid-mediated OqxAB is an important mechanism for nitrofurantoin resistance in Escherichia coli. Antimicrob Agents Chemother 60(1):537\u2013543","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"3672_CR18","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1093\/jac\/dks222","volume":"67","author":"A Vellinga","year":"2012","unstructured":"Vellinga A, Tansey S, Hanahoe B, Bennett K, Murphy AW, Cormican M (2012) Trimethoprim and ciprofloxacin resistance and prescribing in urinary tract infection associated with Escherichia coli: a multilevel model. J Antimicrob Chemother 67(10):2523\u20132530","journal-title":"J Antimicrob Chemother"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-019-03672-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-019-03672-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-019-03672-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T23:15:42Z","timestamp":1599347742000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-019-03672-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,7]]},"references-count":18,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3672"],"URL":"https:\/\/doi.org\/10.1007\/s10096-019-03672-2","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,7]]},"assertion":[{"value":"14 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Rotterdam Study has been approved by the Medical Ethics Committee of the Erasmus MC (registration number MEC 02.1015) and by the Dutch Ministry of Health, Welfare and Sport (Population Screening Act WBO, license number 1071272\u2013159521-PG). All participants provided written informed consent to participate in the study and to have their information obtained from treating physicians.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"None of the funders had any role in design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}